Biomerica Inc (BMRA) stock
BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3049% below fair value
$1.24−0.08 (-6.44%)
Close on Nov 17, 2026Market cap $5.68MP/E –Yield –
Biomerica total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
No total debt figures for Biomerica
Biomerica has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?